Study: Extended use of nicotine patch shows reduced relapse in smokers
PHILADELPHIA Annals of Internal Medicine, a journal of the American College of Physicians.—Future ex-smokers who use a nicotinepatch therapy longer than currently recommended may be less likely to relapse, according to a study published last month in the
Over the course of a placebo-controlled trial from September 2004 through February 2008, 568 adult smokers were randomly assigned GlaxoSmithKline’s Nicoderm CQ for the product-recommended eight weeks followed by use of a placebo patch for 16 weeks, or use of the Nicoderm CQ patch for the full 24 weeks.
At the conclusion of the study, those participants who had used the Nicoderm patch for a full 24 weeks were 19.2% more likely to have quit smoking altogether.
Extended therapy not only reduced the risk for lapse, but also increased the chances of recovery from lapses, according to the journal report. There were differences in side effects and adverse events between the two groups.
The study was funded by the National Institutes of Health.
Bashas’ rejects Albertsons’ buyout bid
NEW YORK Bashas’ has turned down a nearly $300 million buyout offer from Albertsons, according to published reports.
According to an American City Business Journals article, the Chandler, Ariz.-based Bashas’ was uninterested in a buyout offer of $290 million for the chain.
Bashas’ filed for Chapter 11 bankruptcy protection in July, announcing the following month that it would close 14 stores. Still, the published reports quoted an attorney representing the company as saying that the reorganization plan would ensure Bashas’ remained in the hands of the Bashas family, which has owned it since 1932.
Shoppers’ new initiatives sets chain up to become retail giant
WHAT IT MEANS AND WHY IT’S IMPORTANT While the decision to move in this direction may have been made before Chong Bang crossed the border, there is no questioning that industry watchers will be focused on what SDM’s new top merchant will do to further improve the stores.
(THE NEWS: Shoppers Drug Mart takes a page out of CCR playbook. For the full story, click here)
That has a lot to do with Bang’s pedigree — he’s directed a significant merchandising program at Walgreens, one of the leading pureplay pharmacies in the United States. And now he’s at Shoppers, the leading drug store retailer north of the border.
Bang will be armed at Shoppers with the sales data generated by 9.7 million members of the pharmacy’s Optimum loyalty program, 80% of whom are women. When you consider that there are only 34 million Canadians, that means that almost 1-in-3 Canadians are members of Shoppers’ loyalty program, and almost 1-in-2 Canadian women.
Presently, Shoppers plans to grow its square footage at a clip of 8% to 9% with a new distribution center slated to open in 2010 to help support that growth. And that’s really going to be Bang’s merchandising challenge — finding a way to slip one more item into that Shoppers marketbasket in a saturated marketplace. Bang certainly can’t build front-end sales by attracting new customers. There just aren’t that many Canadians who don’t already shop at Shoppers.
For Bang, it’ll be a question of optimizing categorical synergies and in doing so help drive impulse purchases. Similar to Walgreens, Shoppers is on a mission to make a good shopping experience better, and Bang’s expected to help realize that goal.